Questions Circle INDs; Industry Needs Guidance For Probiotics, Say Experts
This article was originally published in The Tan Sheet
Executive Summary
FDA should consider issuing a guidance for probiotics similar to the 2004 industry guidance for botanical drugs, panelists said at a recent Drug Information Association conference